SciTransfer
Expertise area

Biomedical and clinical research

5 European H2020 organizations list this as part of their work5 as their primary capability.

Top organizations

Most active in this area

  • LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN

    Germany's leading research university in molecular biosciences and translational medicine, with 303 H2020 projects and exceptional ERC grant concentration.

    Health-sector projects including CATCH ME (atrial fibrillation/stroke), NEPHSTROM (diabetic kidney disease), FORECEE (cancer prediction), and ALEC (lung disease) show broad clinical engagement.

    PrimaryDE303 projects
  • UNIVERSITAT ZURICH

    Major Swiss research university excelling in neuroscience, biomedical research, and computational science with 50+ ERC grants and global collaboration reach.

    Health sector projects spanning cancer imaging (GLINT), spinal cord injury therapy (NISCI), HIV vaccine development (EHVA), antibiotic resistance diagnostics (DIAGORAS), and epigenetic reprogramming (REPROGRAM).

    PrimaryCH234 projects
  • UNIVERSITAET MUENSTER

    Major German research university strong in biomedical research, advanced materials, geoinformatics, and AI, with extensive MSCA training network experience across 63 countries.

    13 health-sector projects including diagnostics (HYPMED breast PET/MRI), myelodysplastic syndrome (MDS-RIGHT), small vessel diseases (SVDs-at-target), and multiple sclerosis research.

    PrimaryDE110 projects
  • UNIVERZITA KARLOVA

    Major Czech research university strong in NLP/machine translation, biomedical research, climate economics, and mathematical sciences across 107 H2020 projects.

    Projects spanning Parkinson's disease trials (FAIR-PARK-II), cancer prediction (FORECEE), sepsis diagnostics (SMARTDIAGNOS), dementia technology (INDUCT), and human biomonitoring (HBM4EU).

    PrimaryCZ107 projects
  • LUDWIG BOLTZMANN GESELLSCHAFT OSTERREICHISCHE VEREINIGUNG ZUR FORDERUNG DER WISSENSCHAFTLICHEN FORSCHUNG

    Austrian applied research society specializing in biomedical sciences, rare disease diagnostics, tissue engineering, and digital heritage technologies across 15 H2020 projects.

    Core involvement in TRAIN-ERS (ER stress/disease mechanisms), EAVI2020 (AIDS vaccine), ARREST BLINDNESS (corneal therapies), iDysChart (immune dysregulation), and RejuvenateBone (bone regeneration).

    PrimaryAT15 projects